Is p21 an oncogene?

被引：78

作者：

Gartel, Andrei L. ^{[1
]}

机构：

[1] Univ Illinois, Dept Med, Chicago, IL 60612 USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2006年 / 5卷 / 06期

关键词：

D O I：

10.1158/1535-7163.MCT-06-0163

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：1385 / 1386

页数：2

相关论文

共 29 条

[1]

Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model [J].

Adnane, J ;

Jackson, RJ ;

Nicosia, SV ;

Cantor, AB ;

Pledger, WJ ;

Sebti, SM .

ONCOGENE, 2000, 19 (47) :5338-5347

[2]

Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression:: Implications for carcinogenesis, senescence, and age-related diseases [J].

Chang, BD ;

Watanabe, K ;

Broude, EV ;

Fang, J ;

Poole, JC ;

Kalinichenko, TV ;

Roninson, IB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4291-4296

[3]

Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SD11 [J].

Coqueret, O ;

Gascan, H .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) :18794-18800

[4]

DELACUEVA E, 2006, ONCOGENE

[5]

p21WAF1/Cip1:: more than a break to the cell cycle? [J].

Dotto, GP .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2000, 1471 (01) :M43-M56

[6]

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity [J].

Franklin, DS ;

Godfrey, VI ;

O'Brien, DA ;

Deng, CX ;

Xiong, Y .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) :6147-6158

[7]

p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor α [J].

Fritah, A ;

Saucier, U ;

Mester, J ;

Redeuilh, G ;

Sabbah, M .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) :2419-2430

[8]

The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis [J].

Gartel, AL .

LEUKEMIA RESEARCH, 2005, 29 (11) :1237-1238

[9]

Gartel AL, 2002, MOL CANCER THER, V1, P639

[10]

Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138